| Systemic Lupus Erythematosus |
1 |
1 |
| Lupus |
0 |
0.81 |
| Dermatitis |
0 |
0.77 |
| Cutaneous Lupus Erythematosus |
0 |
0.67 |
| Lupus Nephritis |
0 |
0.63 |
| Corticosteroids |
0 |
0.27 |
| Receptors |
0 |
0.27 |
| Biologic Therapy |
0 |
0.22 |
| Monoclonal Antibody |
0 |
0.2 |
| Otolaryngology |
0 |
0.18 |
| Id Reaction |
0 |
0.14 |
| Intravenous |
0 |
0.14 |
| Nephritis |
0 |
0.14 |
| Upper Respiratory Tract Infection |
0 |
0.1 |
| Arthritis |
0 |
0.07 |
| Bronchitis |
0 |
0.07 |
| Central Nervous System |
0 |
0.07 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.07 |
| Cough |
0 |
0.07 |
| Dizziness |
0 |
0.07 |
| Emesis |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Fatigue |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Headache |
0 |
0.07 |
| Myositis |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Respiratory Tract |
0 |
0.07 |